Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Long-Term Debt Issuances (2020)

Aclaris Therapeutics (ACRS) has 1 years of Long-Term Debt Issuances data on record, last reported at -$37000.0 in Q2 2020.

  • For Q2 2020, Long-Term Debt Issuances changed N/A year-over-year to -$37000.0; the TTM value through Dec 2020 reached $10.9 million, changed N/A, while the annual FY2020 figure was $10.9 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached -$37000.0 in Q2 2020 per ACRS's latest filing, down from $11.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $11.0 million in Q1 2020 and bottomed at -$37000.0 in Q2 2020.